The paper deals with the cholesterol–cyclosporine A (Chol–CsA) monolayers at the air/water interface investigated using the Langmuir trough coupled with the Brewster’s angle microscopy. The compressed films were transferred onto the PEEK polymer support by means of the Langmuir–Blodgett technique. To improve molecules adhesion and organization the PEEK surface was treated with air plasma before thin films deposition. The obtained surfaces were characterized by means of atomic force microscope (AFM). Then, the wettability of the supported monolayers was determined by the contact angle measurements. Finally, the surface free energy and its components were evaluated from the theoretical approach proposed by van Oss et al. The obtained results reveal correlation between properties of the Langmuir monolayers at the air/water interface and those of the Langmuir–Blodgett films on PEEK. This was found to be helpful for understanding the wettability of organized molecular films on the polymer support as far as biocompatibility improve is concerned. The preparation of films with defined polarity and various compositions is an important step in the development of polymer surfaces with increased biofunctionality. It is believed that the results presented in this paper can be exploited in the in vivo studies.

This paper presents an overview of the possibilities of testing various cyclosporine (CsA) formulations with an emphasis on parameters that may be key to improving the stability and biocompatibility. The feasibility of CsA colloidal systems for oral (injection) administration were investigated using different techniques and compared with similar investigations of other researchers. The chosen CsA systems were developed using dipalmitoylphosphocholine (DPPC) and/or cholesterol as a lipid matrix, stabilized with ethanol, with soybean oil or n-tetradecane as oil phase in emulsions, under natural pH, room and physiological temperature. Their integrity was found to be strictly dependent on the stabilizers. The highest CsA penetrability with the system containing phospholipid in the context of its interactions with lipid membranes was shown. Also, the bioavailability of CsA can be enhanced with the biopolymer antibacterial chitosan. This mini-review suggests the suitability of liposome/microemulsion as promising vehicles for CsA delivery. The most hopeful proved to be formulation with the smaller particle size facilitating absorption, but when safety is assessed, relying on just the particle size cannot be the only criteria. Reassumed, the CsA formulation stability known on the basis of the size and zeta potential measurements guarantees a decrease of the individual variations in the drug bioavailability, toxicity and minimizes rejection.

Polyetheretherketone (PEEK) is a biocompatible, chemically and physically stable radiolucent polymer that exhibits a similar elastic modulus to the normal human bone, making it an attractive orthopedic implant material. However, PEEK is biologically inert, preventing strong enough bonding with the surrounding bone tissue when implanted in vivo. Surface modification and composite preparation are the two main strategies for the improvement of the bioactivity of PEEK. In this study, the plasma activated PEEK surfaces with the embedded bioglass, chitosan, and bioglass-chitosan mixed layers applying from the solution dip-coating technique were investigated. The most prominent factors affecting the coating biocompatibility are strictly connected with the composition of its outer surface (its charge and functional groups), hydrophilic-hydrophobic character, wettability and surface free energy, and topography (size of pores/substructures, roughness, stiffness), as well as the personal characteristics of the patient. The obtained surfaces were examined in terms of wettability and surface-free energy changes. Additionally, FTIR (Fourier Transformation Infrared Spectrometry) and SIMS (Secondary Ion Mass Spectrometry) were applied to establish and control the coating composition. Simultaneously the structure of coatings was visualized with the aid of SEM (Scanning Electron Microscopy). Finally, the obtained systems were incubated in SBF (Simulated Body Fluid) to verify the modifications’ influence on the bioactivity/biocompatibility of the PEEK surface. Different structures with variable compositions, as well as changes of the wettability, were observed depending on the applied modification. In addition, the incubation in SBF suggested that the bioglass-chitosan ratio influenced the formation of apatite-like structures on the modified PEEK surfaces.

Polyetheretherketone (PEEK) biomaterial is a polymer which has been widely used since the early 90s as a material for human bone implant preparations. Nowadays it is increasingly used due to its high biocompatibility and easily modeling, as well as better mechanical properties and price compared to counterparts made of titanium or platinum alloys. In this paper, air low-temperature and pressure plasma was used to enhance PEEK adhesive properties as well as surface sterilization. On the activated polymeric carrier, biologically-active substances have been deposited with the Langmuir-Blodgett technique. Thereafter, the surface was characterized using optical profilometry, and wettability was examined by contact angle measuring. Next, the contact angle hysteresis (CAH) model was used to calculate the surface free energy of the modified surface of PEEK. The variations of wettability and surface free energy were observed depending on the deposited monolayer type and its components.